Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A Loss of Epigenetic Control Can Promote Cell Death through Reversing the Balance of Pathways in a Signaling Network.

Molecular cell | 2018

Epigenetic control of regulatory networks is only partially understood. Expression of Insulin-like growth factor-II (IGF2) is controlled by genomic imprinting, mediated by silencing of the maternal allele. Loss of imprinting of IGF2 (LOI) is linked to intestinal and colorectal cancers, causally in murine models and epidemiologically in humans. However, the molecular underpinnings of the LOI phenotype are not clear. Surprisingly, in LOI cells, we find a reversal of the relative activities of two canonical signaling pathways triggered by IGF2, causing further rebalancing between pro- and anti-apoptotic signaling. A predictive mathematical model shows that this network rebalancing quantitatively accounts for the effect of receptor tyrosine kinase inhibition in both WT and LOI cells. This mechanism also quantitatively explains both the stable LOI phenotype and the therapeutic window for selective killing of LOI cells, and thus prevention of epigenetically controlled cancers. These findings suggest a framework for understanding epigenetically modified cell signaling.

Pubmed ID: 30244832 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


MDM2 (C-18) (antibody)

RRID:AB_2143674

This polyclonal targets MDM2

View all literature mentions

beta-Arrestin 1/2 (D24H9) Rabbit mAb (antibody)

RRID:AB_10547883

This monoclonal targets beta-Arrestin 1/2 (D24H9) Rabbit mAb

View all literature mentions

Bax (6A7) (antibody)

RRID:AB_626728

This monoclonal targets BAX

View all literature mentions

Bcl-xL (H-5) (antibody)

RRID:AB_626739

This monoclonal targets Bcl-xL (H-5)

View all literature mentions

Bak (G-23) (antibody)

RRID:AB_2063265

This unknown targets epitope mapping within an internal region of Bak of human origin

View all literature mentions

Bcl-2 (C-2) (antibody)

RRID:AB_626736

This monoclonal targets Bcl-2 (C-2)

View all literature mentions

Monoclonal Anti-alpha-Tubulin antibody produced in mouse (antibody)

RRID:AB_477582

This monoclonal targets alpha-Tubulin antibody produced in mouse

View all literature mentions

Bax (D2E11) Rabbit mAb (antibody)

RRID:AB_10557411

This monoclonal targets Bax (D2E11) Rabbit mAb

View all literature mentions

c-Myc (D84C12) XP Rabbit mAb (antibody)

RRID:AB_1903938

This monoclonal targets c-Myc (D84C12) XP Rabbit mAb

View all literature mentions

Phospho-MEK1/2 (Ser217/221) (41G9) Rabbit mAb (antibody)

RRID:AB_2138017

This monoclonal targets Phospho-MEK1/2 (Ser217/221)

View all literature mentions

Insulin Receptor β (4B8) Rabbit mAb (antibody)

RRID:AB_2280448

This recombinant monoclonal targets Insulin Receptor beta

View all literature mentions

IGF-I Receptor (D23H3) XP Rabbit mAb (antibody)

RRID:AB_10950969

This monoclonal targets IGF-I Receptor (D23H3) XP Rabbit mAb

View all literature mentions

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb (antibody)

RRID:AB_2315112

This monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)

View all literature mentions

Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (antibody)

RRID:AB_2315049

This monoclonal targets Phospho-Akt (Ser473)

View all literature mentions

MATLAB (software resource)

RRID:SCR_001622

Multi paradigm numerical computing environment and fourth generation programming language developed by MathWorks. Allows matrix manipulations, plotting of functions and data, implementation of algorithms, creation of user interfaces, and interfacing with programs written in other languages, including C, C++, Java, Fortran and Python. Used to explore and visualize ideas and collaborate across disciplines including signal and image processing, communications, control systems, and computational finance.

View all literature mentions